Literature DB >> 28205254

Manganese and selenium concentrations in cerebrospinal fluid of seriously ill children.

Tomáš Franěk1, Karel Kotaška1, Richard Průša1.   

Abstract

BACKGROUND: The homeostasis of essential trace elements such as selenium and manganese may be altered in patients with severe diseases of various etiologies (trauma brain injuries, tumors, leukemias, lymphomas, neurological diseases).
METHODS: Concentration of manganese and selenium were determined in cerebrospinal fluid by electrothermal atomic absorption spectrometry in 50 hospitalized children with various clinical ethiologies including oncological, neurological, and brain related diseases.
RESULTS: The concentrations of manganese in cerebrospinal fluid of children were 0.97±0.67 μg/L. The concentrations of selenium were 13.3±3.5 μg/L. The concentrations were similar as published in adults. The values did not correlated with the age, gender and severity of the disease.
CONCLUSION: We evaluated values of selenium and manganese in cerebrospinal fluid of seriously diseased children.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  cerebrospinal fluid; children; electrothermal atomic absorption spectroscopy; manganese; selenium; values

Mesh:

Substances:

Year:  2017        PMID: 28205254      PMCID: PMC6817268          DOI: 10.1002/jcla.22122

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  11 in total

1.  Selenium concentration in cerebrospinal fluid samples from a paediatric population.

Authors:  Mireia Tondo; Juan Moreno; Mercedes Casado; Nuria Brandi; Cristina Sierra; Maria A Vilaseca; Aida Ormazabal; Rafael Artuch
Journal:  Neurochem Res       Date:  2010-05-11       Impact factor: 3.996

2.  Trace elements in cerebrospinal fluid and blood from patients with a rare progressive central and peripheral demyelinating disease.

Authors:  Kristin Gellein; Jon H Skogholt; Jan Aaseth; Gunnar B Thoresen; Syverin Lierhagen; Eiliv Steinnes; Tore Syversen; Trond Peder Flaten
Journal:  J Neurol Sci       Date:  2007-09-27       Impact factor: 3.181

3.  A case control study of CSF copper, iron and manganese in Parkinson disease.

Authors:  G C Gazzaniga; B Ferraro; M Camerlingo; L Casto; M Viscardi; A Mamoli
Journal:  Ital J Neurol Sci       Date:  1992-04

4.  Manganese and selenium concentrations in cerebrospinal fluid of seriously ill children.

Authors:  Tomáš Franěk; Karel Kotaška; Richard Průša
Journal:  J Clin Lab Anal       Date:  2017-02-15       Impact factor: 2.352

5.  Elemental profile of cerebrospinal fluid in patients with Parkinson's disease.

Authors:  Alessandro Alimonti; Beatrice Bocca; Anna Pino; Flavia Ruggieri; Giovanni Forte; Giuseppe Sancesario
Journal:  J Trace Elem Med Biol       Date:  2007-07-03       Impact factor: 3.849

6.  Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson's disease.

Authors:  G Forte; B Bocca; O Senofonte; F Petrucci; L Brusa; P Stanzione; S Zannino; N Violante; A Alimonti; G Sancesario
Journal:  J Neural Transm (Vienna)       Date:  2004-03-19       Impact factor: 3.575

7.  Concentrations of Ag, Al, Au, Bi, Cd, Cu, Pb, Sb, and Se in cerebrospinal fluid of patients with cerebral neoplasms.

Authors:  A El-Yazigi; I Al-Saleh; O Al-Mefty
Journal:  Clin Chem       Date:  1984-08       Impact factor: 8.327

8.  Cerebrospinal fluid selenium and chromium levels in patients with Parkinson's disease.

Authors:  M V Aguilar; F J Jiménez-Jiménez; J A Molina; I Meseguer; C J Mateos-Vega; M J González-Muñoz; F de Bustos; C Gómez-Escalonilla; M Ort-Pareja; M Zurdo; M C Martínez-Para
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

9.  Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease.

Authors:  Lars Gerhardsson; Thomas Lundh; Lennart Minthon; Elisabet Londos
Journal:  Dement Geriatr Cogn Disord       Date:  2008-05-05       Impact factor: 2.959

10.  Impact of selenium, iron, copper and zinc in on/off Parkinson's patients on L-dopa therapy.

Authors:  G A Qureshi; A A Qureshi; S A Memon; S H Parvez
Journal:  J Neural Transm Suppl       Date:  2006
View more
  3 in total

1.  Manganese and selenium concentrations in cerebrospinal fluid of seriously ill children.

Authors:  Tomáš Franěk; Karel Kotaška; Richard Průša
Journal:  J Clin Lab Anal       Date:  2017-02-15       Impact factor: 2.352

2.  SLC39A8 deficiency: biochemical correction and major clinical improvement by manganese therapy.

Authors:  Julien H Park; Max Hogrebe; Manfred Fobker; Renate Brackmann; Barbara Fiedler; Janine Reunert; Stephan Rust; Konstantinos Tsiakas; René Santer; Marianne Grüneberg; Thorsten Marquardt
Journal:  Genet Med       Date:  2017-07-27       Impact factor: 8.822

Review 3.  Association between peripheral manganese levels and attention-deficit/hyperactivity disorder: a preliminary meta-analysis.

Authors:  Jun-Hao Shih; Bing-Yan Zeng; Pao-Yen Lin; Tien-Yu Chen; Yen-Wen Chen; Ching-Kuan Wu; Ping-Tao Tseng; Ming-Kung Wu
Journal:  Neuropsychiatr Dis Treat       Date:  2018-07-18       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.